C₂₂₅H₃₄₈N₄₈O₆₈

MOUNVIA

Tirzepatide

MOUNVIA is presented within HMD as an investigational system for scientific reading and molecular characterization. This profile connects the molecule with related historical and technical documentation within the HMD series.

Type	Dual GIP and GLP-1 receptor agonist
Chemical / scientific name	Synthetic linear 39-amino-acid peptide modified with a C20 diacid moiety; based on human GIP with specific substitutions and lysine side-chain modifications.
Molecular formula	C₂₂₅H₃₄₈N₄₈O₆₈

Technical profile

This profile is part of a documentary library of investigational systems. It does not constitute a clinical indication, therapeutic recommendation, prescription, commercial availability, or instructions for use.

Related literature

Research dossier

HMD-ED-002 — MOUNVIA Evidence Dossier

Tirzepatide · Full Technical Brief. Document viewer for client-facing technical consultation, integrated into the molecular profile of the investigational system.

Technical viewer

Loading dossier...